The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NCI9673: A multi-institutional eETCTN phase II study of nivolumab in refractory metastatic squamous cell carcinoma of the anal canal (SCCA).
 
Van Karlyle Morris
No Relationships to Disclose
 
Kristen Keon Ciombor
Research Funding - Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; MedImmune; Onyx; Pfizer
 
Mohamed E. Salem
No Relationships to Disclose
 
Halla Sayed Nimeiri
No Relationships to Disclose
 
Syma Iqbal
Honoraria - Bristol-Myers Squibb; Celgene; Novartis
Consulting or Advisory Role - Genentech/Roche
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Novartis
Research Funding - Bayer/Onyx
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Genentech/Roche; Genentech/Roche; Novartis
 
Preet Paul Singh
Consulting or Advisory Role - Bayer; Merrimack
 
Blase N. Polite
Speakers' Bureau - Bayer/Onyx
Research Funding - Merck
Other Relationship - Gerson Lehrman Group
 
Dustin A. Deming
No Relationships to Disclose
 
Emily Chan
Consulting or Advisory Role - Amgen; Bayer; Castle Biosciences; EMD Serono; Lilly; Taiho Pharmaceutical
Speakers' Bureau - EMD Serono
Research Funding - Aduro Biotech; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Dekkun Corporation; Halozyme; Karyopharm Therapeutics; Merrimack; Millennium; Taiho Pharmaceutical
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Celgene; Seagen
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly; NCCN; Pfizer; Regeneron; Research to Practice; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Polaris
 
Hope Elizabeth Uronis
Employment - GeneCentric (I)
Research Funding - Abbott Laboratories; Bristol-Myers Squibb; Genentech/Roche; Merrimack; Sanofi
 
Manolo G Pasia
No Relationships to Disclose
 
Gail Bland
No Relationships to Disclose
 
Robert A. Wolff
Honoraria - Precision Medicine Research Associates, LLC; The Queens Health System
Consulting or Advisory Role - Clovis Oncology; Precision Medicine Research Associates, LLC
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
Travel, Accommodations, Expenses - London Health Sciences Centre (LHSC)
 
Aki Ohinata
No Relationships to Disclose
 
Chimela Ohaji
No Relationships to Disclose
 
Jane Rogers
No Relationships to Disclose
 
Padmanee Sharma
Leadership - Evelo Therapeutics; Jounce Therapeutics; Jounce Therapeutics (I); Neon Therapeutics (I); SAB-Pharma; SAB-Pharma (I)
Stock and Other Ownership Interests - Evelo Therapeutics; Jounce Therapeutics; Jounce Therapeutics (I); Kite, a Gilead company; Kite, a Gilead company (I); Neon Therapeutics (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline
Research Funding - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Own patent licensed to Jounce; Own patents licensed to BMS, Jounce & Merck (I)
 
Cathy Eng
Honoraria - Lilly; Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech
Research Funding - ArQule; Keryx
Travel, Accommodations, Expenses - Genentech/Roche